MedPath

Sulbutiamine

Generic Name
Sulbutiamine
Drug Type
Small Molecule
Chemical Formula
C32H46N8O6S2
CAS Number
3286-46-2
Unique Ingredient Identifier
42NCM1BW43

Overview

Sulbutiamine is a synthetic derivative of thiamine (vitamin B1) under the market name Arcalion that is composed of two modified thiamine molecules to form a dimer. It is highly lipophilic, allowing it to cross the blood-brain barrier more easily than other thiamine derivatives. Although its clinical efficacy is not yet defined, sulbutiamine is used to treat asthenia. While its other uses include improvement of erectile dysfunction and reduction of psycho-behavioural inhibition, sulbutiamine showed evidence of modulatory effect on dopaminergic and glutamatergic cortical transmissions. The chronic administration of the drug has demonstrated to improve long term memory formation in mice.

Background

Sulbutiamine is a synthetic derivative of thiamine (vitamin B1) under the market name Arcalion that is composed of two modified thiamine molecules to form a dimer. It is highly lipophilic, allowing it to cross the blood-brain barrier more easily than other thiamine derivatives. Although its clinical efficacy is not yet defined, sulbutiamine is used to treat asthenia. While its other uses include improvement of erectile dysfunction and reduction of psycho-behavioural inhibition, sulbutiamine showed evidence of modulatory effect on dopaminergic and glutamatergic cortical transmissions. The chronic administration of the drug has demonstrated to improve long term memory formation in mice.

Indication

No indication information available.

Associated Conditions

  • Asthenia

Clinical Trials

Not Applicable
Recruiting
Posted: 2024/07/12

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

ARCALION TABLET 200 MG
Manufacturer:LES LABORATOIRES SERVIER INDUSTRIE
Form:TABLET, SUGAR COATED
Strength:200 mg
Online:Yes
Approved: 1991/05/03
Approval:SIN06159P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath